GSK Investigational Site

Hemer, North Rhine-Westphalia 58675

0 studies enrolling now · 3 studies all time

What they study most

Lung Cancer, Non-Small Cell, Thrombocytopaenia

Studies at this site

• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
• Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma — Stopped early
• SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy — Completed